Hypocalcaemia in patients with metastatic bone disease treated with denosumabJean-Jacques Body, Paul J. Kostenuik, Karim Fizazi et al.|European Journal of Cancer|2015Cited by 150
Osteopetrosis rescue upon RANKL administration to <i>Rankl</i>−<i>/</i>− mice: A new therapy for human RANKL-dependent ARONadia Lo Iacono, Cristina Sobacchi, Harry C. Blair et al.|Journal of Bone and Mineral Research|2012Cited by 54
The development of denosumab for the treatment of diseases of bone loss and cancer‐induced bone destructionCarsten Goessl, Rachel B. Wagman, Leonid Katz et al.|Annals of the New York Academy of Sciences|2012Cited by 41